emerg
sever
acut
respiratori
syndrom
sar
sober
remind
devast
local
global
effect
new
pathogen
inflict
highli
contagi
diseas
spread
rapidli
within
commun
intern
via
air
travel
carri
mortal
rate
hand
rapid
isol
character
novel
sar
coronaviru
sarscov
etiolog
agent
diseas
result
intern
cooper
among
public
health
offici
collabor
laboratori
world
health
organ
center
diseas
control
ongo
worldwid
surveil
requir
sensit
specif
assay
earli
detect
two
current
use
serolog
test
enzymelink
immunosorb
assay
elisa
indirect
immunofluoresc
assay
ifa
accur
sar
diagnosi
convalesc
phase
viral
titer
high
howev
low
viral
load
incub
period
rang
day
first
week
symptom
hamper
earli
detect
increas
sensit
provid
realtim
revers
transcriptasepolymeras
chain
reaction
rtpcr
current
assay
identifi
one
region
sarscov
sequenc
cdc
recommend
document
one
genom
sequenc
definit
confirm
insid
issu
juang
et
p
introduc
improv
method
combin
multiplex
rtpcr
mrtpcr
diagnost
gene
chip
assay
techniqu
highli
sensit
detect
copi
sarscov
specif
use
multipl
sequencespecif
probe
recogn
one
genom
region
appli
clinic
sampl
allow
accur
detect
confirm
even
semiquantit
estim
viral
load
expans
gene
chip
could
even
allow
simultan
assay
coronavirus
relat
respiratori
pathogen
virul
pathogen
appear
match
aggress
intern
multidisciplinari
public
health
countermeasur
new
assay
help
juang
jl
chen
tc
jiang
ss
et
al
coupl
multiplex
rtpcr
gene
chip
assay
sensit
semiquantit
detect
sever
acut
respiratori
syndromecoronaviru
lab
invest
extravas
plasma
plasma
protein
vasculatur
key
featur
inflammatori
respons
give
rise
characterist
swell
soft
tissu
mobil
neutrophil
circul
interstiti
space
wellestablish
induc
plasma
extravas
neutrophil
mobil
respons
presenc
proinflammatori
bacteri
product
releas
chemotact
factor
complement
presenc
necrot
cellular
debri
contrast
cellular
apoptosi
incit
inflammatori
reaction
rather
monocyt
pattern
leukocyt
emigr
ensu
unaccompani
neutrophil
emigr
tissu
swell
premis
monocytepredomin
tissu
infiltr
induc
plasma
extravas
directli
test
issu
miyamoto
et
p
use
guineapig
induc
monocytepredomin
subcutan
infiltr
intraderm
inject
crosslink
homodim
ribosom
protein
rp
dimer
protein
releas
apoptot
cell
plasma
extravas
occur
occur
anim
elev
peripher
blood
monocyt
level
occur
despit
coinject
prostaglandin
vasodilatori
agent
rp
dimer
agonist
chemotact
receptor
monocyt
antagonist
neutrophil
chemotact
receptor
author
show
plasma
extravas
occur
coinject
rp
dimer
neutrophil
extravas
occur
henc
one
must
conclud
plasma
extravas
specif
neutrophil
inflammatori
respons
result
physic
leakag
plasma
monocyt
emmigr
limit
respons
apoptosi
highli
advantag
given
routin
occurr
apoptosi
quiet
pattern
monocyt
infiltr
tissu
develop
remodel
miyamoto
k
kitamoto
tokunaga
h
et
al
protect
effect
vascular
endotheli
growth
factorvascular
permeabl
factor
glomerular
endotheli
cell
injuri
rat
lab
invest
ir
injuri
caus
signific
morbid
associ
trauma
organ
transplant
addit
us
navi
navi
interest
quit
pathobiolog
postischem
reperfus
injuri
occur
treatment
decompress
sick
regardless
manner
injuri
reintroduct
blood
flow
follow
ischemia
caus
deleteri
case
irrevers
effect
tissu
function
effect
attribut
toxic
metabolit
oxygen
radic
relat
neutrophil
recent
nitric
oxid
level
regul
synthetas
ii
no
ii
emerg
possibl
mediat
no
ii
local
almost
exclus
mast
cell
issu
bortolotto
et
p
present
definit
evid
mast
cell
skelet
muscl
play
regulatori
role
patholog
ir
injuri
tissu
prior
public
group
other
report
mast
celldefici
mice
less
suscept
develop
necrosi
ir
injuri
wildtyp
mice
strain
current
studi
use
mast
celldeplet
mice
engraft
bone
marrowderiv
mast
cell
normal
litterm
subject
ir
injuri
reconstitut
anim
show
significantli
decreas
skelet
muscl
viabil
compar
nonengraft
mast
celldefici
control
work
confirm
mast
cell
contribut
skelet
muscl
injuri
postischem
reperfus
studi
widerang
implic
understand
mechan
ir
injuri
treat
condit
associ
patholog
anchor
lower
mast
cell
ahead
full
bortolotto
sk
morrison
wa
han
xl
et
al
mast
cell
play
pivot
role
ischemia
reperfus
injuri
skelet
muscl
lab
invest
viru
ebv
ubiquit
member
herpesviru
famili
establish
lifelong
persist
infect
human
popul
worldwid
follow
primari
infect
viru
persist
b
cell
usual
harmless
passeng
howev
ebv
transform
b
cell
may
result
develop
lymphoprolif
diseas
approxim
burkitt
lymphoma
bl
unit
state
contain
ebv
dna
viru
etiolog
link
genesi
tumor
link
ebv
bl
support
evid
ebv
infect
preced
develop
malign
tumor
although
precis
pathogenet
mechan
may
permit
ebv
induc
bl
remain
unclear
ebv
genom
present
bl
cell
multipl
nuclear
episom
also
evid
chromosom
integr
viral
genom
bl
line
integr
may
import
mechan
interact
ebv
cellular
gene
particularli
involv
cellgrowth
regul
tumorigenesi
analysi
integr
ebv
dna
complic
presenc
episom
form
ebv
nucleoplasm
issu
luo
et
p
examin
human
bl
cell
line
nab
contain
one
copi
ebv
dna
integr
chromosom
region
host
genom
site
may
amplifi
bcell
hodgkin
lymphoma
author
clone
breakpoint
site
ebv
integr
host
chromosom
dna
found
integr
site
near
gene
rel
gene
known
involv
tumorigenesi
rna
process
rel
encod
nfkappab
transcript
factor
encod
zincfing
transcript
factor
overexpress
bcell
hodgkin
lymphoma
furthermor
express
level
rel
increas
perhap
due
dysregul
caus
integr
event
addit
author
found
transcript
viral
gene
may
disrupt
event
understand
oncogen
potenti
ebv
remain
challeng
task
although
episom
express
ebv
protein
may
play
import
role
tumorigenesi
studi
show
integr
ebv
dna
host
genom
could
repres
anoth
oncogen
mechan
integr
site
overlap
gene
encod
protein
biolog
critic
tumorigenesi
luo
wj
takakuwa
ham
mf
et
al
viru
integr
rel
american
burkitt
lymphoma
cell
line
lab
invest
